SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?


To: Gary Mohilner who wrote (5634)1/15/2020 3:02:16 PM
From: Wildbiftek  Read Replies (1) | Respond to of 5665
 
It's unlikely that they will announce a transformative deal, but they might provide some color on how they will finance the bevy of new trials through readout that they have planned:

investor.immunogen.com

The structure of any deal hopefully doesn't give up too much ownership of Mirvetuxemab S. prior to the readout of SORAYA.